Late-Onset Seizures: Trial of Vascular Risk Investigation and Treatment
Recruiting
Observational Study
Epilepsy
Seizure
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 50 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 420 (estimated)
- Sponsor
- Sahlgrenska University Hospital · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
A growing body of evidence suggests patients with late-onset seizures are at an increased risk of stroke, but the potential for reducing cardiovascular morbidity through risk factor screening and management is unknown.
The investigators aim to determine whether individuals with new-onset unprovoked seizures after middle age should undergo vascular risk assessment. In a cluster project the investi…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria
Clinical study:
\- First assessment for unprovoked seizures or epilepsy with onset after age 50 -- - vascular risk factor evaluation per the new routine at participating care givers
Register study:
* age ≥50 with a first-ever outpatient appointment to one of the participating …
Contacts